N-hydroxy-2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]pyrimidine-5-carboxamide
N-hydroxy-2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]pyrimidine-5-carboxamide
PubChem CID: 11538455
Quisinostat is a member of the class of methylindoles that is 1H-indole substituted by methyl and [({1-[5-(hydroxycarbamoyl)pyrimidin-2-yl]piperidin-4-yl}methyl)amino]methyl groups at positions 1 and 3, respectively. It is an orally bioavailable pan-HDAC inhibitor that exhibits antineoplastic activity. It has a role as a radiosensitizing agent, an autophagy inducer, an antineoplastic agent, an antimalarial, a bone density conservation agent and an EC 3.5.1.98 (histone deacetylase) inhibitor. It is a hydroxamic acid, a member of piperidines, a methylindole, a member of pyrimidines and a secondary amino compound.
Canonical SMILES
SMILES: This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to QUISINOSTAT